Currently, few studies report biofunctions of LDH-C4 in tumor cells, and some find that LDHC mRNA is expressed in various tumors with positive rates of expressions of its spliceosomes up to 47% in lung cancer, 44% in melanoma, 35% in breast cancer and 15% in colon cancer [17]. Here, LDHC is linked to breast carcinoma.